Dr. John P Griffin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7980 Fax: 207-283-7793 |
Dr. Michelle Lea Ramirez, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 24 W Cole Rd Ste 104, Biddeford, ME 04005 Phone: 160-228-3207 |
Cynthia Tien-bao Chao, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr Ste 204, Biddeford, ME 04005 Phone: 207-284-2630 |
Dr. John P Nadeau, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr Ste 204, Biddeford, ME 04005 Phone: 207-284-2630 |
Robert J Doiron, MD, MAS Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr, Biddeford, ME 04005 Phone: 207-284-2630 |
James W Georgitis, MD, FACS Surgery Medicare: Not Enrolled in Medicare Practice Location: 3 Medical Center Dr, Biddeford, ME 04005 Phone: 207-284-4597 Fax: 207-282-9213 |
Michael Carroll, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Drive, Suite 204, Biddeford, ME 04005 Phone: 207-284-2630 Fax: 207-284-2631 |
Dr. Natalie Ann Calcatera, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-284-2630 |
Catherine A Share, MD Surgery Medicare: Medicare Enrolled Practice Location: 9 Healthcare Dr, Suite 204, Biddeford, ME 04005 Phone: 207-284-2630 Fax: 207-284-2631 |
David Grubb, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr, Biddeford, ME 04005 Phone: 207-284-2631 |
News Archive
A Fox Business report shows the health overhaul is cutting deeper into drug and device makers' profits than many expected. Research & development programs are already being drastically scaled back.
In an update of the project portfolio, Karo Bio announced, among other things, that the company, in accordance with earlier communicated plans, has submitted an IND application for eprotirome to the American Food and Drug Administration (FDA); that a candidate drug has been nominated within the ER-beta program; and that the company has decided not to initiate further in-house development of KB3305 for the treatment of type 2 diabetes.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors will drive the psoriasis drug market to increase from $3 billion in 2008 to $5.2 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
With grilled chicken, salads and oatmeal now on fast food menus, you might think fast food has become healthier. And indeed, there has been greater attention in the media and legislatively, paid to the healthfulness of fast food. But a close look at the industry has found that calorie counts have changed little, while the number of food items has doubled.
› Verified 9 days ago